The present invention relates to the use of probiotic microorganism in the
manufacture of a composition for the prevention or reduction of
gastrointestinal Campylobacter infection in a mammalian animal. It also
relates to a method for the prevention or reduction of gastrointestinal
Campylobacter infection in a mammalian animal, the method comprising
administering to said animal, a probiotic microorganism. The invention
also relates to a probiotic microorganism, for use in preventing or
reducing gastrointestinal Campylobacter infection in a mammalian animal.